Xue Jun Su
Direktor/Vorstandsmitglied bei SSY GROUP LIMITED
Vermögen: 15 Mio $ am 30.04.2024
Aktive Positionen von Xue Jun Su
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SSY GROUP LIMITED | Direktor/Vorstandsmitglied | 15.12.2014 | - |
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
 New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Direktor/Vorstandsmitglied | 07.01.2007 | - |
Karriereverlauf von Xue Jun Su
Ehemalige bekannte Positionen von Xue Jun Su
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Shijiazhuang No 1 Pharmaceutical Factory | Corporate Officer/Principal | 01.01.1990 | - |
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Direktor/Vorstandsmitglied | 01.01.2002 | - |
| Vorsitzender | - | - | |
| Corporate Officer/Principal | 01.01.2002 | - |
Ausbildung von Xue Jun Su
| Hebei Normal University | Undergraduate Degree |
Statistik
International
| China | 4 |
| Hong Kong | 2 |
Operativ
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Chairman | 1 |
Sektoral
| Health Technology | 3 |
| Finance | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SSY GROUP LIMITED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Finance |
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Health Technology |
| Shijiazhuang No 1 Pharmaceutical Factory |
- Börse
- Insiders
- Xue Jun Su
- Erfahrung
